The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 801 Mounjaro articles
Trey Luker-Stewart lost 60 pounds on Ozempic, but it transformed his drinking from fun nights to anxious, emotional ones with brutal hangovers. As a Dallas bar owner, he's seen a 35% drop in alcohol sales linked to GLP-1 drugs. Doctors reveal why these medications blunt alcohol's rewards and worsen next-day effects.
Eli Lilly is dominating the GLP-1 market with 25% projected growth in 2026, outpacing Novo Nordisk's decline. Their new Employer Connect platform could unlock massive demand for Zepbound by filling employer coverage gaps. Meanwhile, orforglipron shows superior results over Rybelsus in key trials.
Obesity rates hit 40% in 2022, but GLP-1 drugs are turning the tide with 15-20% weight loss. USC Schaeffer Center research shows broad access could add nearly two years of life for young adults and save Medicare $175-245 billion. Yet, limited insurance coverage blocks millions from these life-changing treatments.
A large real-world study from Cleveland Clinic reveals mixed outcomes after GLP-1 discontinuation: 55% of obese patients regained weight, while 45% maintained or continued losing. Many switched to alternative treatments, highlighting the need for ongoing obesity care. This data underscores gaps in long-term management and the role of nutritional support.
Chronic kidney disease affects over one in seven Americans, but new drugs like Ozempic are changing the game. GLP-1 receptor agonists, SGLT2 inhibitors, and finerenone offer additive benefits beyond traditional RAS inhibitors, potentially halting or reversing progression. Experts like Maarten Taal hail them as game-changers for kidney health.
Kelly Osbourne's black sequined mini dress at the BRIT Awards turned heads for more than fashion—her slimmer frame ignited Ozempic speculation. Joined by Demi Moore, Emma Stone, and others at 2026 red carpets, these stars' dramatic weight loss sparked debates on 'Ozempic face' and Hollywood beauty standards. Discover the details and medical context.
Melissa McCarthy turned heads at the 2026 Oscars in a stunning gown, but her noticeably slimmer face reignited Ozempic rumors. Side-by-side pics with her 2012 Oscars appearance make the change crystal clear. Onstage, she even poked fun at the speculation during a Bridesmaids reunion.
At the Oscars 2026 red carpet, an overwhelming uniformity of extremely slender bodies and sunken cheeks dominated, raising questions about Ozempic and GLP-1 agonists. Celebrities like Demi Moore, Emma Stone, and Oprah Winfrey appeared dramatically thinner, contrasting the body positivity era. Is Hollywood reverting to 'heroin chic' aesthetics?
South African DJ Shimza set the record straight on Podcast and Chill, firmly denying rumors that his impressive weight loss came from Ozempic or that he profits from government tenders. With his partner Athi Geleba in a high-profile Presidency position, speculation ran wild—but Shimza insists he earns his money through hard work. This candid interview sheds light on celebrity health rumors and tender controversies.
